Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Asit_Parikh
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
drug discovery
molecular machines |
| gptkbp:foundedYear |
2020
|
| gptkbp:fundedBy |
gptkb:Omega_Funds
gptkb:Casdin_Capital gptkb:Third_Rock_Ventures gptkb:Norwest_Venture_Partners gptkb:Boxer_Capital gptkb:Cormorant_Asset_Management GV (formerly Google Ventures) |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
MOMA Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:scientificAdvisoryBoardMember |
gptkb:Alan_D._Frankel
gptkb:Susan_Lindquist gptkb:James_Berger gptkb:David_Sabatini gptkb:Nathanael_Gray gptkb:John_Kuriyan gptkb:Kevan_Shokat |
| gptkbp:specializesIn |
targeting ATPases
|
| gptkbp:website |
https://www.momatherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Third_Rock_Ventures
|
| gptkbp:bfsLayer |
6
|